Viridian Therapeutics, Inc.\DE (VRDN) › RevenueViridian Therapeutics, Inc.\DE (VRDN) — RevenueAnnual figures by fiscal year, from SEC filings.2017: $4.00M2018: $8.39M2019: $4.46M2020: $1.05M2021: $2.96M2022: $1.77M2023: $314.0K2024: $302.0K2025: $70.85M$70.85M2017Revenue (USD)2025Fiscal YearRevenueChange YoY2025$70.85M+23359.9%2024$302.0K-3.8%2023$314.0K-82.3%2022$1.77M-40.2%2021$2.96M+182.2%2020$1.05M-76.5%2019$4.46M-46.8%2018$8.39M+109.5%2017$4.00M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share